Dai Lizhong, actual controller and chairman of Shengxiang Biotech (688289.SH), proposes to enhance shareholders' dividend returns

Zhitongcaijing · 6d ago

Zhitong Finance App News, Shengxiang Biotech (688289.SH) announced that the company recently received a “Letter on Proposing Enhancing Shareholders' Dividend Returns and Implementing the Company's 2024 “Improving Quality, Efficiency, and Valuing Returns” Action Plan issued by Dai Lizhong, the company's actual controller and chairman.

Dai Lizhong proposed that from 2024 to 2026, the company's annual profit distributed in cash (including mid-year dividends and annual dividends for the current year) should not be less than RMB 300 million (tax included), and the cumulative profit distributed in cash for three consecutive years should not be less than RMB 900 million (tax included).